|
|
 |
| |
|
|
|
|
|
|
|
|
 |
New salt form of amlodipine comparable to amlodipine besylate |
|
FDA approved amlodipine salt |
|
Well-tolerated antihypertensive and antianginal agent |
|
|
|
|
 |
|
 |
|
Each tablet contains 6.42mg of amlodipine maleate (5mg as amlodipine)
|
Hypertension, chronic stable angina, vasospasmodic angina(Prinzmetal’s or variant angina)
Adults: The usual initial oral dose of SKAD is 5 mg as amlodipine once daily with a maximum dose of 10 mg once daily. The dosage might be adjusted according to the age or symptoms of the patient.
| 1. | SKAD is a long-acting calcium channel blocker that dilates peripheral arteries to cause a reduction in peripheral vascular resistance. |
| 2. |
SKAD has been confirmed to be therapeutically equivalent to amlodipine besylate in the treatment of mild to moderate hypertension by the comparative phase III clinical study. |
3. Due to its high efficacy and safety, it guarantees well-tolerability for long-term treatment.
4. It is pharmacoeconomic amlodipine because it costs only 80% compared to amlodipine besylate. |
|
 |
|
|
|
